BioDlink International Co Ltd Sustainability Reports
The company operates an integrated CDMO/CMO platform that develops, manufactures, and commercializes oncology drugs, monoclonal antibodies, and antibody-drug conjugates (ADCs).
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG00BSCQ9X4
7 reports from 2019 to 2025
